I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
1-Deamino-8-D-arginine vasopressin makes a new pharmacological approach to the management of haemophilia and von Willebrand's disease. A novel nonenzymatic pathway for the generation of nitric oxide is by the reaction of hydrogen peroxide and d- or l-arginine.
Sohji Nagase,; Katsumi Takemura,; Atsushi Ueda,; Aki Hirayama,; Kazumasa Aoyagi,; Makoto Kondoh,; Akio Koyama. A Novel Nonenzymatic Pathway for the Generation of Nitric Oxide by the Reaction of Hydrogen Peroxide and D- or L-Arginine . Biochemical and Biophysical Research Communications. 1977, 233 (1), 153-154.
A Borchiellini,; K Fijnvandraat,; JW ten Cate,; D Pajkrt,; SJ van Deventer,; G Pasterkamp,; F Meijer-Huizinga,; L Zwart-Huinink,; J Voorberg,; JA van Mourik. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans . Blood. 1966, 88(8).
Hazard Statements: H319
Causes serious eye irritation.
Precautionary Statements: P280i-P264-P305+P351+P338-P337+P313
Wear eye/face protection. Wash thoroughly after handling. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention.